CN102245633A - 新的胰岛素类似物 - Google Patents

新的胰岛素类似物 Download PDF

Info

Publication number
CN102245633A
CN102245633A CN2009801494190A CN200980149419A CN102245633A CN 102245633 A CN102245633 A CN 102245633A CN 2009801494190 A CN2009801494190 A CN 2009801494190A CN 200980149419 A CN200980149419 A CN 200980149419A CN 102245633 A CN102245633 A CN 102245633A
Authority
CN
China
Prior art keywords
desb30
insulin
insulin human
human
human insulin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN2009801494190A
Other languages
English (en)
Chinese (zh)
Inventor
C.E.施蒂德森
T.格伦多夫
T.B.克尔德森
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2009/053017 external-priority patent/WO2009115469A1/en
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of CN102245633A publication Critical patent/CN102245633A/zh
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CN2009801494190A 2008-12-09 2009-12-03 新的胰岛素类似物 Withdrawn CN102245633A (zh)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
EP08171086 2008-12-09
EP08171086.5 2008-12-09
PCT/EP2009/053017 WO2009115469A1 (en) 2008-03-18 2009-03-13 Protease stabilized, acylated insulin analogues
EPPCT/EP2009/053017 2009-03-13
EP09161014.7 2009-05-25
EP09161014 2009-05-25
EP09161232 2009-05-27
EP09161232.5 2009-05-27
PCT/EP2009/066335 WO2010066636A1 (en) 2008-12-09 2009-12-03 Novel insulin analogues

Publications (1)

Publication Number Publication Date
CN102245633A true CN102245633A (zh) 2011-11-16

Family

ID=41651437

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009801494190A Withdrawn CN102245633A (zh) 2008-12-09 2009-12-03 新的胰岛素类似物

Country Status (5)

Country Link
US (1) US20110294729A1 (enExample)
EP (1) EP2376531A1 (enExample)
JP (1) JP2012511506A (enExample)
CN (1) CN102245633A (enExample)
WO (1) WO2010066636A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110072884A (zh) * 2016-07-22 2019-07-30 犹他大学研究基金会 胰岛素类似物

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2910570T (pt) 2008-03-18 2017-01-24 Novo Nordisk As Análogos de insulina acilados, estabilizados contra proteases
JP6013330B2 (ja) 2010-06-23 2016-10-25 ノヴォ ノルディスク アー／エス 追加のジスルフィド結合を含有するヒトインスリン
EP2585484A1 (en) * 2010-06-23 2013-05-01 Novo Nordisk A/S Insulin analogues containing additional disulfide bonds
KR20130036290A (ko) 2010-06-23 2013-04-11 노보 노르디스크 에이/에스 추가 이황화 결합을 함유하는 인슐린 유도체
BR112014025132A2 (pt) 2012-04-11 2017-07-11 Novo Nordisk As formulações de insulina
AU2013325099B2 (en) * 2012-09-25 2018-11-15 The Walter And Eliza Hall Institute Of Medical Research Structure of insulin in complex with n- and c-terminal regions of the insulin receptor alpha-chain
US20140269611A1 (en) * 2013-03-14 2014-09-18 T-Mobile Usa, Inc. Communication Handovers from Networks Using Unlicensed Spectrum to Circuit-Switched Networks
PT3554534T (pt) 2016-12-16 2021-11-05 Novo Nordisk As Composições farmacêuticas contendo insulina
BR112021011050A2 (pt) 2018-12-11 2021-08-31 Sanofi Ligante peptídico

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990012814A1 (en) * 1989-04-20 1990-11-01 Mount Sinai School Of Medicine Of The City University Of New York Hepatospecific insulin analogues
US6746853B1 (en) * 1999-05-19 2004-06-08 Xencor, Inc. Proteins with insulin-like activity useful in the treatment of diabetes
WO2008034881A1 (en) * 2006-09-22 2008-03-27 Novo Nordisk A/S Protease resistant insulin analogues

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR900701842A (ko) * 1988-07-20 1990-12-04 헨리 브뢰늄 인간 인슐린 동족체와 그를 포함하는 제제
US5716927A (en) * 1988-12-23 1998-02-10 Novo Nordisk A/S Insulin analogs having a modified B-chain
US5268453A (en) * 1991-08-08 1993-12-07 Scios Inc. Tissue-selective insulin analogs
JP2003518917A (ja) * 1999-05-19 2003-06-17 ゼンコー 糖尿病の処置に有用なインシュリン様活性を有する新規タンパク質
CN101970477B (zh) * 2008-03-14 2014-12-31 诺沃-诺迪斯克有限公司 蛋白酶稳定的胰岛素类似物
PT2910570T (pt) * 2008-03-18 2017-01-24 Novo Nordisk As Análogos de insulina acilados, estabilizados contra proteases

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990012814A1 (en) * 1989-04-20 1990-11-01 Mount Sinai School Of Medicine Of The City University Of New York Hepatospecific insulin analogues
US6746853B1 (en) * 1999-05-19 2004-06-08 Xencor, Inc. Proteins with insulin-like activity useful in the treatment of diabetes
WO2008034881A1 (en) * 2006-09-22 2008-03-27 Novo Nordisk A/S Protease resistant insulin analogues

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110072884A (zh) * 2016-07-22 2019-07-30 犹他大学研究基金会 胰岛素类似物
CN110072884B (zh) * 2016-07-22 2023-07-28 犹他大学研究基金会 胰岛素类似物

Also Published As

Publication number Publication date
EP2376531A1 (en) 2011-10-19
US20110294729A1 (en) 2011-12-01
JP2012511506A (ja) 2012-05-24
WO2010066636A1 (en) 2010-06-17

Similar Documents

Publication Publication Date Title
US12071456B2 (en) Extended recombinant polypeptides and compositions comprising same
CN102245633A (zh) 新的胰岛素类似物
CN104662038B (zh) 胰高血糖素类似物
JP5695909B2 (ja) 極度に遅延した時間作用プロファイルを有する新規なインスリン誘導体
JP6006309B2 (ja) 作用持続期間が増大し、免疫原性が減少した操作されたポリペプチド
CN109836488B (zh) 一种治疗代谢疾病的胰高血糖素类似物
CN101970477B (zh) 蛋白酶稳定的胰岛素类似物
AU2008365559A1 (en) Glucagon analogues
JP2022513776A (ja) インスリン受容体結合親和性が低下したインスリンアナログ
JP2009532422A (ja) Ｇｌｐ−１ペプチドアゴニスト
US20140057841A1 (en) Human insulin and analog conjugate thereof
WO2025162138A1 (zh) 一种超长效胰岛素类似物及其制备方法和用途
EP3257523A1 (en) Use of polypeptide complex as polypeptide or protein drug carrier, method, and fusion protein complex thereof
US11179444B2 (en) Glucagon analogs and methods of use thereof
AU2014206217B2 (en) Extended recombinant polypeptides and compositions comprising same
KR102094103B1 (ko) 폴리펩티드를 포함하는 당뇨병 예방 또는 치료용 약학 조성물
AU2017200870B2 (en) Extended recombinant polypeptides and compositions comprising same
WO2015193378A1 (en) Novel glp-1 receptor agonists with cholesterol efflux activity
HK1238255B (en) Extended recombinant polypeptides and compositions comprising same
HK1238255A1 (en) Extended recombinant polypeptides and compositions comprising same
HK1161887B (en) Extended recombinant polypeptides and compositions comprising same
HK1135993B (en) Glucagon/glp-1 receptor co-agonists

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C04 Withdrawal of patent application after publication (patent law 2001)
WW01 Invention patent application withdrawn after publication

Application publication date: 20111116